MYNZ

Mainz Biomed N.V. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website mainzbiomed.com
Employees(FY) 58
ISIN NL0015000LC2

Performance

+56.92%

+51.75%

-32.16%

-49.49%

+60.19%

YTD

-82.16%

Profile

Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.

Advanced Technical Analysis

Technical Analysis of MYNZ 2025-02-03

The stock exhibits a generally bullish sentiment, with a strong Moving Average Score of 70 indicating positive momentum, while the Oscillators Score of 56 suggests a neutral stance. Overall, the combined Technical Score of 66 reinforces the bullish outlook, signaling potential upward movement in the stock's price.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of MYNZ

Stock Rank

Recent News & Updates

2024-05-27 20:01
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting(Globenewswire)
2024-05-19 20:01
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial(Globenewswire)
2024-05-16 19:23
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday(Investorplace)
2024-05-15 22:51
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game(Yahoo Finance)
2024-05-06 20:01
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.(Globenewswire)
2024-04-29 00:02
mRNA Is Promising A Breakthrough In Fighting Cancer(Yahoo Finance)
2024-04-24 21:29
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic(Globenewswire)
2024-04-10 00:47
The Pharmaceutical Industry Finds Itself At A Historical Crossroads(Yahoo Finance)
2024-04-09 09:53
MYNZ Stock Earnings: Mainz Biomed Beats EPS, Misses Revenue for Q4 2023(Investorplace)
2024-04-08 20:01
Mainz Biomed Reports Full Year 2023 Financial Results(Globenewswire)
2024-03-18 20:01
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment(Globenewswire)
2024-03-17 20:01
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options(Globenewswire)
2024-03-11 20:01
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations(Yahoo Finance)
2024-03-07 23:00
What Makes Mainz Biomed NV (MYNZ) a New Buy Stock(Zacks)
2024-03-04 19:01
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic(Globenewswire)
2024-02-27 23:54
Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening(Yahoo Finance)
2024-02-26 19:01
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community(Globenewswire)
2024-02-22 01:21
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment(Yahoo Finance)
2024-02-21 19:01
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®(Yahoo Finance)
2024-02-20 19:01
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy(Yahoo Finance)
2024-02-06 23:13
2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front(Yahoo Finance)
2024-02-05 19:01
Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany(Globenewswire)
2024-02-01 03:17
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle(Yahoo Finance)
2024-01-10 19:01
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gda sk Gastroenterology Symposium(Globenewswire)
2024-01-09 02:40
2024 Marks a New Era Of Pharmaceutical Innovation(Yahoo Finance)
2024-01-08 19:01
Mainz Biomed Provides Year-End Corporate Review 2023(Globenewswire)
2023-12-29 01:48
2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer(Yahoo Finance)
2023-12-18 19:01
Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees(Globenewswire)
2023-12-11 19:01
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland(Yahoo Finance)
2023-12-05 01:06
While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer(Yahoo Finance)

Page 2 of 5

previous next

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.